Literature DB >> 12627099

Amalgam-contact hypersensitivity lesions and oral lichen planus.

Martin H Thornhill1, Michael N Pemberton, Raymond K Simmons, Elizabeth D Theaker.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the relationship between amalgam restorations and oral lichen planus. STUDY
DESIGN: Eighty-one patients with oral lichenoid lesions were characterized clinically and skin patch tested for amalgam or mercury hypersensitivity. Thirty-three of these patients had amalgam fillings in contact with oral lesions replaced and were followed to determine the outcome.
RESULTS: Clinically, 2 patient groups were identified: (1) 30 patients with probable amalgam-contact hypersensitivity lesions (ACHLs) and (2) 51 patients with oral lichen planus (OLP) but no clear relationship with amalgam. Seventy percent of ACHL cases were patch test positive for amalgam or mercury compared with only 3.9% of OLP cases (P < .0001). Amalgam replacement resulted in lesion improvement in 93% of ACHL cases. No such improvement was observed in the OLP cases treated (P < .001).
CONCLUSION: OLP is a heterogeneous condition within which an ACHL subgroup can be identified. ACHLs, but not other OLP lesions, respond favorably to amalgam replacement. A strong clinical association between lesions and amalgam restorations plus a positive patch test result was a good predictor of lesion improvement on amalgam replacement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627099     DOI: 10.1067/moe.2003.115

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  17 in total

1.  Amalgam contact hypersensitivity lesion: an unusual presentation-report of a rare case.

Authors:  Bk Ramnarayan; Pm Maligi; T Smitha; Us Patil
Journal:  Ann Med Health Sci Res       Date:  2014-09

2.  Low Prevalence of Amalgam-Associated Lichenoid Lesions in the Oral Cavity: A Prospective Study.

Authors:  Pankaj Gupta; Shivani Mallishery; Nikita Bajaj; K Banga; Ashna Mehra; Rajiv Desai
Journal:  Cureus       Date:  2022-02-28

3.  Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B - A pilot prospective study.

Authors:  Upender Malik; Siddharth Gupta; Shilpa D Malik; Shirin Vashishth; M S Raju
Journal:  Saudi Dent J       Date:  2012-06-26

4.  Clinical characteristics of oral lichen planus and its causal context with dental restorative materials and oral health-related quality of life.

Authors:  Linda Daume; Constance Kreis; Lauren Bohner; Susanne Jung; Johannes Kleinheinz
Journal:  BMC Oral Health       Date:  2021-05-15       Impact factor: 2.757

5.  Oral lichenoid lesions associated with amalgam restorations: a prospective pilot study addressing the adult population of the Basque Country.

Authors:  M-J Lartitegui-Sebastián; B Martínez-Revilla; C Saiz-Garcia; S Eguizabal-Saracho; J-M Aguirre-Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-07-01

6.  Mast cells distribution and variations in epithelium thickness and basement membrane in oral lichen planus lesion and oral lichenoid reaction.

Authors:  Gholamreza Jahanshahi; Parichehr Ghalayani; Laleh Maleki
Journal:  Dent Res J (Isfahan)       Date:  2012-03

7.  Determination of susceptibility to sensitization to dental materials in atopic and non-atopic patients.

Authors:  G Rojas-Alcayaga; A Carrasco-Labra; P Danús; M-A Guzmán; I Morales-Bozo; B Urzúa; A Ortega-Pinto
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-03-01

8.  Salivary IgA and IgG in oral lichen planus and oral lichenoid reactions diseases.

Authors:  Parichehr Ghaleyani; Farimah Sardari; Mojtaba Akbari
Journal:  Adv Biomed Res       Date:  2012-10-31

Review 9.  Oral lichenoid contact lesions to mercury and dental amalgam--a review.

Authors:  Helen McParland; Saman Warnakulasuriya
Journal:  J Biomed Biotechnol       Date:  2012-07-24

10.  Salivary levels of tumor necrosis factor-alpha in oral lichen planus.

Authors:  Sonja Pezelj-Ribaric; Ivana Brekalo Prso; Maja Abram; Irena Glazar; Gordana Brumini; Marica Simunovic-Soskic
Journal:  Mediators Inflamm       Date:  2004-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.